ES2110256T3 - Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina. - Google Patents

Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina.

Info

Publication number
ES2110256T3
ES2110256T3 ES94925560T ES94925560T ES2110256T3 ES 2110256 T3 ES2110256 T3 ES 2110256T3 ES 94925560 T ES94925560 T ES 94925560T ES 94925560 T ES94925560 T ES 94925560T ES 2110256 T3 ES2110256 T3 ES 2110256T3
Authority
ES
Spain
Prior art keywords
ligands
dopamine receptor
receptor subtypes
heteroaromatic derivatives
derivatives fused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94925560T
Other languages
English (en)
Inventor
Ian James Collins
Paul David Leeson
Michael Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2110256T3 publication Critical patent/ES2110256T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UNA CLASE DE COMPUESTOS HETEROAROMATICOS TRICICLICOS UNIDOS DE FORMULA (I), O UNA SAL DE LOS MISMOS O UN PROFARMACO DE LOS MISMOS QUE CONTIENE UN ANILLO DE PIRAZOL UNIDO SON LIGANDOS DE SUBTIPOS RECEPTORES DE DOPAMINA EN EL CUERPO Y SON POR ELLO UTILES EN EL TRATAMIENTO Y/O PREVENCION DE ENFERMEDADES DEL SISTEMA DE DOPAMINA, COMO ESQUIZOFRENIA.
ES94925560T 1993-09-09 1994-09-06 Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina. Expired - Lifetime ES2110256T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939318691A GB9318691D0 (en) 1993-09-09 1993-09-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2110256T3 true ES2110256T3 (es) 1998-02-01

Family

ID=10741750

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94925560T Expired - Lifetime ES2110256T3 (es) 1993-09-09 1994-09-06 Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina.

Country Status (10)

Country Link
US (1) US5686480A (es)
EP (1) EP0717733B1 (es)
JP (1) JPH09502199A (es)
AT (1) ATE160773T1 (es)
AU (1) AU684304B2 (es)
CA (1) CA2168738A1 (es)
DE (1) DE69407191T2 (es)
ES (1) ES2110256T3 (es)
GB (1) GB9318691D0 (es)
WO (1) WO1995007262A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19519056A1 (de) * 1995-05-24 1997-01-16 Klinge Co Chem Pharm Fab Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
WO2000012500A2 (en) * 1998-09-02 2000-03-09 Neurogen Corporation 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US6462036B1 (en) 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
WO2003024935A2 (en) * 2001-09-19 2003-03-27 Pharmacia Corporation Substituted pyrazolyl compounds for the treatment of inflammation
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
US7462717B2 (en) 2002-08-21 2008-12-09 Janssen Pharmaceutica N.V. C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants
AP2527A (en) 2006-10-31 2012-12-06 Pfizer Prod Inc Pyrazoline compounds as mineralocorticoid receptorantagonists
AU2008249745B2 (en) * 2007-05-09 2012-01-12 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
US20110263588A1 (en) * 2008-10-27 2011-10-27 Glaxo Group Limited Tricyclic compounds as glutamate receptor modulators
DE102010055499A1 (de) * 2010-12-22 2011-06-16 W.C. Heraeus Gmbh Prozess zur Herstellung von Bendamustinalkylester, Bendarmustin sowie Derivaten davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553230A (en) * 1967-09-26 1971-01-05 Colgate Palmolive Co 3-aminoalkyl and 3-amino derivatives of 4h(1)benzopyrano(3,4-d)isoxazoles
US3969527A (en) * 1975-07-28 1976-07-13 E. R. Squibb & Sons, Inc. CNS active compounds
ES2076253T3 (es) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
JPH08502958A (ja) * 1992-10-23 1996-04-02 メルク シヤープ エンド ドーム リミテツド ドーパミンレセプターサブタイプリガンド

Also Published As

Publication number Publication date
AU684304B2 (en) 1997-12-11
WO1995007262A1 (en) 1995-03-16
ATE160773T1 (de) 1997-12-15
EP0717733B1 (en) 1997-12-03
DE69407191T2 (de) 1998-07-02
EP0717733A1 (en) 1996-06-26
JPH09502199A (ja) 1997-03-04
CA2168738A1 (en) 1995-03-16
DE69407191D1 (de) 1998-01-15
AU7542594A (en) 1995-03-27
US5686480A (en) 1997-11-11
GB9318691D0 (en) 1993-10-27

Similar Documents

Publication Publication Date Title
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
AR027406A1 (es) Moduladores de receptores canabinoides, sus procesos de preparacion y uso de los moduladores de receptores canabinoides para el tratamiento de enfermedadesrespiratorias y no respiratorias.
CL2022000102A1 (es) Derivados de 6,7-dihidro-5h-pirido[2,3-c]piridazin-8-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos.
ES2102488T3 (es) Naftopiranos fotocromicos.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
MX9500224A (es) Procedimiento para la obtencion de poliolefina.
ATE160774T1 (de) Antipsychotische benzimidazolderivate
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
ES2145911T3 (es) Compuestos de naftopirano fotocromicos.
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
ES2071334T3 (es) Analogos de anillos fusionados de nitrogeno conteniendo heterociclos no aromaticos.
SV2002000195A (es) Compuestos farmaceuticamente activos ref. pcs10342 afae/bb
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
AR048567A1 (es) Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas.
UY38809A (es) Derivados de 3,6-diamino-piridazin-3ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos
PE20020144A1 (es) Derivados de pleuromutilinas como agentes antibacterianos
CL2020001817A1 (es) Moduladores del receptor c5a
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
MX9306679A (es) Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene.
ATE160773T1 (de) Kondensierte tricyclische heteroaromatische verbindungen als dopamin-rezeptor-subtyp-liganden
ES2102043T3 (es) Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos.
CO4810376A1 (es) Derivados de eritromicina triciclicos
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 717733

Country of ref document: ES